EQUASENS (EQS.PA) Stock Fundamental Analysis
EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to EQS. EQS was compared to 11 industry peers in the Health Care Technology industry. EQS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EQS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year EQS was profitable.
EQS had a positive operating cash flow in the past year.
EQS had positive earnings in each of the past 5 years.
Each year in the past 5 years EQS had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 9.10%, EQS belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
EQS has a Return On Equity of 15.65%. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
EQS has a Return On Invested Capital of 12.02%. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EQS is significantly above the industry average of 7.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROIC | 12.02% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
EQS has a Profit Margin of 16.72%. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
In the last couple of years the Profit Margin of EQS has remained more or less at the same level.
EQS has a Operating Margin of 20.18%. This is amongst the best in the industry. EQS outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of EQS has declined.
With a Gross Margin value of 68.77%, EQS is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
EQS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EQS is creating value.
The number of shares outstanding for EQS remains at a similar level compared to 1 year ago.
Compared to 5 years ago, EQS has more shares outstanding
Compared to 1 year ago, EQS has an improved debt to assets ratio.
2.2 Solvency
EQS has an Altman-Z score of 4.55. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of EQS (4.55) is better than 90.91% of its industry peers.
EQS has a debt to FCF ratio of 1.29. This is a very positive value and a sign of high solvency as it would only need 1.29 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 1.29, EQS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
EQS has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
EQS has a Debt to Equity ratio of 0.12. This is in the better half of the industry: EQS outperforms 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Altman-Z | 4.55 |
ROIC/WACC1.57
WACC7.66%
2.3 Liquidity
A Current Ratio of 1.21 indicates that EQS should not have too much problems paying its short term obligations.
EQS has a Current ratio of 1.21. This is comparable to the rest of the industry: EQS outperforms 54.55% of its industry peers.
A Quick Ratio of 1.10 indicates that EQS should not have too much problems paying its short term obligations.
The Quick ratio of EQS (1.10) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.02%.
EQS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.12% yearly.
Looking at the last year, EQS shows a decrease in Revenue. The Revenue has decreased by -1.37% in the last year.
EQS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.45% yearly.
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
3.2 Future
Based on estimates for the next years, EQS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.54% on average per year.
Based on estimates for the next years, EQS will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y27.31%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.26%
Revenue Next 2Y11.8%
Revenue Next 3Y9.29%
Revenue Next 5Y7.74%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.71, which indicates a rather expensive current valuation of EQS.
Based on the Price/Earnings ratio, EQS is valued cheaper than 90.91% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.25, EQS is valued a bit cheaper.
EQS is valuated correctly with a Price/Forward Earnings ratio of 16.96.
63.64% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
EQS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.71 | ||
| Fwd PE | 16.96 |
4.2 Price Multiples
EQS's Enterprise Value to EBITDA is on the same level as the industry average.
63.64% of the companies in the same industry are more expensive than EQS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.91 | ||
| EV/EBITDA | 12.48 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EQS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as EQS's earnings are expected to grow with 18.54% in the coming years.
PEG (NY)0.76
PEG (5Y)4.04
EPS Next 2Y18.54%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.49%, EQS has a reasonable but not impressive dividend return.
EQS's Dividend Yield is a higher than the industry average which is at 3.69.
Compared to an average S&P500 Dividend Yield of 2.40, EQS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.49% |
5.2 History
The dividend of EQS is nicely growing with an annual growth rate of 8.00%!
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
51.86% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
EQS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.86%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPA:EQS (5/30/2025, 7:00:00 PM)
49.5
-0.7 (-1.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners13.44%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap750.91M
Analysts76.67
Price Target60.69 (22.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.49% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.86%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.57%
PT rev (3m)-14.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.71 | ||
| Fwd PE | 16.96 | ||
| P/S | 3.46 | ||
| P/FCF | 20.91 | ||
| P/OCF | 15.79 | ||
| P/B | 3.24 | ||
| P/tB | 9.2 | ||
| EV/EBITDA | 12.48 |
EPS(TTM)2.39
EY4.83%
EPS(NY)2.92
Fwd EY5.9%
FCF(TTM)2.37
FCFY4.78%
OCF(TTM)3.13
OCFY6.33%
SpS14.29
BVpS15.26
TBVpS5.38
PEG (NY)0.76
PEG (5Y)4.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROCE | 14.76% | ||
| ROIC | 12.02% | ||
| ROICexc | 14.31% | ||
| ROICexgc | 35.95% | ||
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% | ||
| FCFM | 16.57% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexcg growth 3Y-25.09%
ROICexcg growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Debt/EBITDA | 0.48 | ||
| Cap/Depr | 79.39% | ||
| Cap/Sales | 5.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | 99.11% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 4.55 |
F-Score5
WACC7.66%
ROIC/WACC1.57
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
EPS Next Y27.31%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
Revenue Next Year9.26%
Revenue Next 2Y11.8%
Revenue Next 3Y9.29%
Revenue Next 5Y7.74%
EBIT growth 1Y-20.84%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year71.53%
EBIT Next 3Y25.63%
EBIT Next 5YN/A
FCF growth 1Y-8.64%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-17.61%
OCF growth 3Y0.02%
OCF growth 5Y3.18%